| ESMO Minimum Clinical Recommendations
Acute myelopblastic leukemia (AML) in adult patients
Advanced colorectal cancer
Cancers of unknown primary site (CUP)
Chemotherapy-induced nausea and vomiting (NV)
Colon cancer
Ewing's sarcoma of bone
Hematopoietic growth factors (hGFs)
Invasive bladder cancer
Mixed or non-seminomatous germ cell tumors (NSGCT)
Osteosarcoma
Ovarian cancer
Rectal cancer
Squamous cell carcinoma of the head and neck (SCCHN)
Testicular seminoma
Level of Evidence
|